Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
1.630
0.00 (0.00%)
Jun 6, 2025, 4:00 PM - Market closed
Cocrystal Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 6.92 | 9.86 | 26.35 | 37.14 | 58.71 | 33.01 | Upgrade
|
| Cash & Short-Term Investments | 6.92 | 9.86 | 26.35 | 37.14 | 58.71 | 33.01 | Upgrade
|
| Cash Growth | -68.31% | -62.59% | -29.05% | -36.73% | 77.84% | 345.00% | Upgrade
|
| Accounts Receivable | - | - | - | - | - | 0.56 | Upgrade
|
| Other Receivables | 1.45 | 1.22 | 0.89 | 0.72 | - | - | Upgrade
|
| Receivables | 1.45 | 1.22 | 0.89 | 0.72 | - | 0.56 | Upgrade
|
| Prepaid Expenses | 0.39 | 0.43 | 1.77 | 0.54 | 0.57 | 0.4 | Upgrade
|
| Restricted Cash | 0.08 | 0.08 | 0.08 | 0.08 | 0.05 | 0.05 | Upgrade
|
| Other Current Assets | - | - | - | 1.7 | - | - | Upgrade
|
| Total Current Assets | 8.83 | 11.58 | 29.09 | 40.18 | 59.32 | 34.02 | Upgrade
|
| Property, Plant & Equipment | 1.75 | 1.85 | 2.12 | 0.62 | 0.93 | 1.09 | Upgrade
|
| Goodwill | - | - | - | - | 19.09 | 19.09 | Upgrade
|
| Other Long-Term Assets | 0.09 | 0.03 | 0.05 | 0.05 | 0.05 | 0.05 | Upgrade
|
| Total Assets | 10.66 | 13.46 | 31.26 | 40.84 | 79.39 | 54.24 | Upgrade
|
| Accounts Payable | 0.81 | 1.54 | 1.22 | 0.61 | 0.58 | 0.66 | Upgrade
|
| Accrued Expenses | 0.81 | 0.59 | 1.8 | 0.36 | 0.72 | 0.42 | Upgrade
|
| Current Portion of Leases | 0.31 | 0.3 | 0.24 | 0.24 | 0.24 | 0.22 | Upgrade
|
| Other Current Liabilities | - | - | - | - | 0.01 | 0.06 | Upgrade
|
| Total Current Liabilities | 1.93 | 2.43 | 3.26 | 1.22 | 1.55 | 1.36 | Upgrade
|
| Long-Term Leases | 1.42 | 1.51 | 1.61 | 0.06 | 0.3 | 0.38 | Upgrade
|
| Total Liabilities | 3.36 | 3.93 | 4.88 | 1.27 | 1.84 | 1.74 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.07 | Upgrade
|
| Additional Paid-In Capital | 343.01 | 342.93 | 342.29 | 337.49 | 336.63 | 297.34 | Upgrade
|
| Retained Earnings | -335.72 | -333.42 | -315.91 | -297.93 | -259.09 | -244.91 | Upgrade
|
| Total Common Equity | 7.3 | 9.52 | 26.38 | 39.57 | 77.55 | 52.51 | Upgrade
|
| Shareholders' Equity | 7.3 | 9.52 | 26.38 | 39.57 | 77.55 | 52.51 | Upgrade
|
| Total Liabilities & Equity | 10.66 | 13.46 | 31.26 | 40.84 | 79.39 | 54.24 | Upgrade
|
| Total Debt | 1.73 | 1.81 | 1.85 | 0.3 | 0.53 | 0.6 | Upgrade
|
| Net Cash (Debt) | 5.19 | 8.05 | 24.5 | 36.85 | 58.17 | 32.41 | Upgrade
|
| Net Cash Growth | -74.09% | -67.13% | -33.51% | -36.66% | 79.46% | 391.05% | Upgrade
|
| Net Cash Per Share | 0.51 | 0.79 | 2.54 | 4.52 | 7.90 | 7.04 | Upgrade
|
| Filing Date Shares Outstanding | 10.17 | 10.17 | 10.17 | 8.14 | 8.12 | 5.96 | Upgrade
|
| Total Common Shares Outstanding | 10.17 | 10.17 | 10.17 | 8.14 | 8.12 | 5.87 | Upgrade
|
| Working Capital | 6.9 | 9.15 | 25.83 | 38.96 | 57.78 | 32.66 | Upgrade
|
| Book Value Per Share | 0.72 | 0.94 | 2.59 | 4.86 | 9.55 | 8.94 | Upgrade
|
| Tangible Book Value | 7.3 | 9.52 | 26.38 | 39.57 | 58.46 | 33.41 | Upgrade
|
| Tangible Book Value Per Share | 0.72 | 0.94 | 2.59 | 4.86 | 7.20 | 5.69 | Upgrade
|
| Machinery | 1.92 | 1.92 | 1.91 | 1.76 | 1.69 | 1.62 | Upgrade
|
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.